ConductScience.org, home

Paper351980

The current status of low-dose heparin in the prophylaxis of thrombophlebitis and pulmonary embolism.

Kakkar VV. World J Surg, 1978. Cited by 37 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. The current status of low-dose heparin in the prophylaxis of thrombophlebitis and pulmonary embolism. Papers, record 351980. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/351980

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The current status of low-dose heparin in the prophylaxis of thrombophlebitis and pulmonary embolism.
PubMed
Journal
World J Surg
PubMed
Year
1978
PubMed
Publication types
Clinical Trial, Journal Article
PubMed
Citations, by iCite
37
iCite
Relative citation ratio, by iCite
2.66
iCite
Revised in PubMed
2019-08-23
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kakkar VVV V

Source PubMed

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
HeparinMajor topic
Pulmonary EmbolismMajor topic
ThrombophlebitisMajor topic
Clinical Trials as Topic
Female
Humans
Postoperative Complications
Pregnancy
Pregnancy Complications, Cardiovascular

Source PubMed

References54

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
14,817,700Heparin action.Circulation1974https://conductscience.org/library/papers/4817700PubMed
24,372,746Enhancement of plasminogen activator by vasopressin and adrenaline: a role of cyclic AMP?Thromb Res1974https://conductscience.org/library/papers/4372746PubMed
34,598,979Proceedings: Low dose subcutaneous heparin--optimal dose regimen.Br J Surg1974https://conductscience.org/library/papers/4598979PubMed
4989,965Four heparin preparations: anti-Xa potentiating effect of heparin after subcutaneous injection.Thromb Haemost1976https://conductscience.org/library/papers/989965PubMed
54,740,341Thromboembolism after total hip reconstruction. Failure of low doses of heparin in prevention.JAMA1973https://conductscience.org/library/papers/4740341PubMed
61,036,806Low-dose heparin and deep-vein thrombosis after total hip replacement.Thromb Haemost1976https://conductscience.org/library/papers/1036806PubMed
7790,636Plasma heparin levels after administration of calcium and sodium salts of heparin.Thromb Res1976https://conductscience.org/library/papers/790636PubMed
85,723,724Streptokinase therapy in acute major pulmonary embolism: effectiveness and problems.Br Med J1968https://conductscience.org/library/papers/5723724PubMed
94,138,248Prevention of deep-vein thrombosis by low-dose heparin in patients undergoing total hip replacement.Lancet1974https://conductscience.org/library/papers/4138248PubMed
115,913,480Results in the prophylaxis of postoperative thromboembolism.Surg Gynecol Obstet1966https://conductscience.org/library/papers/5913480PubMed
124,843,085[Prevention of venous thrombosis. Success of high doses of heparin during total hip replacement for osteoarthritis].Nouv Presse Med1974https://conductscience.org/library/papers/4843085PubMed
134,126,560A double-blind trial of low doses of subcutaneous heparin in the prevention of deep-vein thrombosis after myocardial infarction.Lancet1973https://conductscience.org/library/papers/4126560PubMed
145,637,480Highly purified antithrombin 3 with heparin cofactor activity prepared by disc electrophoresis.Scand J Clin Lab Invest1968https://conductscience.org/library/papers/5637480PubMed
155,536,580Urokinase pulmonary embolism trial. Phase 1 results: a cooperative study.JAMA1970https://conductscience.org/library/papers/5536580PubMed
1614,176,888THE CLINICAL USAGE OF HEPARIN.Am J Cardiol1964https://conductscience.org/library/papers/14176888PubMed
174,135,556Heparin versus dextran in the prevention of deep-vein thrombosis. A multi-unit coctrolled trial.Lancet1974https://conductscience.org/library/papers/4135556PubMed
184,107,902Prevention of postoperative deep-vein thrombosis with perioperative subcutaneous heparin.Lancet1971https://conductscience.org/library/papers/4107902PubMed
1958,199Efficacy of low-dose heparin in prevention of extensive deep-vein thrombosis in patients undergoing total-hip replacement.Lancet1976https://conductscience.org/library/papers/58199PubMed
204,164,368The iliofemoral venous segment as a source of pulmonary emboli.Lancet1967https://conductscience.org/library/papers/4164368PubMed
214,744,294125I fibrinogen and the prevention of venous thrombosis.Arch Surg1973https://conductscience.org/library/papers/4744294PubMed

See all 54 references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 37 citations.

PMIDTitleJournalYearIn PapersSource
7,353,128Incidences of fatal postoperative pulmonary embolism after prophylaxis with dextran 70 and low-dose heparin: an international multicentre study.Br Med J1980https://conductscience.org/library/papers/7353128PubMed
3,134,089Effect of low dose heparin on blood loss at caesarean section.Br Med J (Clin Res Ed)1988https://conductscience.org/library/papers/3134089PubMed
3,098,941Venous thromboembolism: epidemiology, diagnosis, prevention.J Gen Intern Med1986https://conductscience.org/library/papers/3098941PubMed
507,970Thrombotic complications of heparin therapy: including six cases of heparin--induced skin necrosis.Ann Surg1979https://conductscience.org/library/papers/507970PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/351980

GET https://conductscience.org/api/papers/v1/351980/references?page=2